PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.70

-0.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jelrod3 who wrote (4250)	7/12/1998 9:05:00 AM
From: Brian P.	Read Replies (1) of 9523

<< The agency is expected to give the drug fast-track review, which could put it on the market by early next year before Merck can submit its clinical results with Vioxx. If that happens, Vioxx may not get fast-track processing-the FDA is reluctant to grant expedited review to drugs that are similar to ones already on the market, says Salomon analyst Heuer....The Pfizer-Searle team could gain an extra six months of market exclusivity if Merck is denied fast review-"easily worth $500 million," says Heuer....>> Do you all think this is a likely scenario? Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next